University of Minnesota research shows people can control a robotic arm with only their minds

December 14, 2016

Researchers at the University of Minnesota have made a major breakthrough that allows people to control a robotic arm using only their minds. The research has the potential to help millions of people who are paralyzed or have neurodegenerative diseases.

The study is published online today in Scientific Reports, a Nature research journal.

"This is the first time in the world that people can operate a robotic arm to reach and grasp objects in a complex 3D environment using only their thoughts without a brain implant," said Bin He, a University of Minnesota biomedical engineering professor and lead researcher on the study. "Just by imagining moving their arms, they were able to move the robotic arm."

The noninvasive technique, called electroencephalography (EEG) based brain-computer interface, records weak electrical activity of the subjects' brain through a specialized, high-tech EEG cap fitted with 64 electrodes and converts the "thoughts" into action by advanced signal processing and machine learning.

Eight healthy human subjects completed the experimental sessions of the study wearing the EEG cap. Subjects gradually learned to imagine moving their own arms without actually moving them to control a robotic arm in 3D space. They started from learning to control a virtual cursor on computer screen and then learned to control a robotic arm to reach and grasp objects in fixed locations on a table. Eventually, they were able to move the robotic arm to reach and grasp objects in random locations on a table and move objects from the table to a three-layer shelf by only thinking about these movements.

All eight subjects could control a robotic arm to pick up objects in fixed locations with an average success rate above 80 percent and move objects from the table onto the shelf with an average success rate above 70 percent.

"This is exciting as all subjects accomplished the tasks using a completely noninvasive technique. We see a big potential for this research to help people who are paralyzed or have neurodegenerative diseases to become more independent without a need for surgical implants," He said.

The researchers said the brain-computer interface technology works due to the geography of the motor cortex--the area of the cerebrum that governs movement. When humans move, or think about a movement, neurons in the motor cortex produce tiny electric currents. Thinking about a different movement activates a new assortment of neurons, a phenomenon confirmed by cross-validation using functional MRI in He's previous study. Sorting out these assortments using advanced signal processing laid the groundwork for the brain-computer interface used by the University of Minnesota researchers, He said.

The robotic arm research builds upon He's research published three years ago in which subjects were able to fly a small quadcopter using the noninvasive EEG technology. The research gained international media attention.

"Three years ago, we weren't sure moving a more complex robotic arm to grasp and move objects using this brain-computer interface technology could even be achieved," He said. "We're happily surprised that it worked with a high success rate and in a group of people."

He anticipates the next step of his research will be to further develop this brain-computer interface technology realizing a brain-controlled robotic prosthetic limb attached to a person's body or examine how this technology could work with someone who has had a stroke or is paralyzed.
-end-
In addition to Professor He, who also serves as director of the University of Minnesota Institute for Engineering in Medicine, the research team includes biomedical engineering postdoctoral researcher Jianjun Meng (first author); biomedical engineering graduate student Bryan Baxter; Institute for Engineering in Medicine staff member Angeliki Bekyo; and biomedical engineering undergraduate students Shuying Zhang and Jaron Olsoe. The researchers are affiliated with the University of Minnesota College of Science and Engineering and the Medical School.

The University of Minnesota study was funded by the National Science Foundation (NSF), the National Center for Complementary and Integrative Health, National Institute of Biomedical Imaging and Bioengineering, and National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH), and the University of Minnesota's MnDRIVE (Minnesota's Discovery, Research and InnoVation Economy) Initiative funded by the Minnesota Legislature.

To read the full research paper, entitled "Noninvasive Electroencephalogram Based Control of a Robotic Arm for Reach and Grasp Tasks," visit the Nature Scientific Reports website.

University of Minnesota

Related Neurodegenerative Diseases Articles from Brightsurf:

Bringing drugs to the brain with nanoparticles to treat neurodegenerative diseases
Researchers from the Institut national de la recherche scientifique (INRS) have shown that nanoparticles could be used to deliver drugs to the brain to treat neurodegenerative diseases.

First 'pathoconnectome' could point toward new treatments for neurodegenerative diseases
Scientists from the John A. Moran Eye Center at the University of Utah have achieved another first in the field of connectomics, which studies the synaptic connections between neurons.

Unlocking the mystery of tau for treatment of neurodegenerative diseases
A team of researchers from various collaborating universities and hospitals in Japan has uncovered crucial molecular details regarding the activity of the ''tau'' protein, promising to revolutionize the therapy of tau-induced neurodegenerative diseases.

Investigational drug stops toxic proteins tied to neurodegenerative diseases
An investigational drug that targets an instigator of the TDP-43 protein, a well-known hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), may reduce the protein's buildup and neurological decline associated with these disorders, suggests a pre-clinical study from researchers at Penn Medicine and Mayo Clinic.

Inhibition of sphingolipid metabolism and neurodegenerative diseases
Disrupting the production of a class of lipids known as sphingolipids in neurons improved symptoms of neurodegeneration and increased survival in a mouse model.

How understanding the dynamics of yeast prions can shed light on neurodegenerative diseases
How understanding the dynamics of yeast prions can shed light on neurodegenerative diseases

New family of molecules to join altered receptors in neurodegenerative diseases
An article published in the Journal of Medicinal Chemistry shows a new family of molecules with high affinity to join imidazoline receptors, which are altered in the brain of those patients with neurodegenerative diseases such as Alzheimer's, Parkinson's and Huntington's.

Examining diagnoses of stress-related disorders, risk of neurodegenerative diseases
Researchers investigated how stress-related disorders (such as posttraumatic stress disorder, adjustment disorder and stress reactions) were associated with risk for neurodegenerative diseases, including Alzheimer and Parkinson disease and amyotrophic lateral sclerosis (ALS), using data from national health registers in Sweden.

Toxic protein, linked to Alzheimer's and neurodegenerative diseases, exposed in new detail
The protein tau has long been implicated in Alzheimer's and a host of other debilitating brain diseases.

Study uncovers unexpected connection between gliomas, neurodegenerative diseases
New basic science and clinical research identifies TAU, the same protein studied in the development of Alzheimer's, as a biomarker for glioma development.

Read More: Neurodegenerative Diseases News and Neurodegenerative Diseases Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.